BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33710528)

  • 1. Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part II. Insights from two MS cases.
    van Rensburg SJ; Hattingh C; Johannes C; Moremi KE; Peeters AV; van Heerden CJ; Erasmus RT; Zemlin AE; Kemp MC; Jaftha M; Khine AA; Potocnik FCV; Whati L; Engel-Hills P; van Toorn R; Kotze MJ
    Metab Brain Dis; 2021 Aug; 36(6):1169-1181. PubMed ID: 33710528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part I. Targeting a metabolic model rather than autoimmunity.
    van Rensburg SJ; van Toorn R; Erasmus RT; Hattingh C; Johannes C; Moremi KE; Kemp MC; Engel-Hills P; Kotze MJ
    Metab Brain Dis; 2021 Aug; 36(6):1151-1167. PubMed ID: 33909200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an iron-responsive subtype in two children diagnosed with relapsing-remitting multiple sclerosis using whole exome sequencing.
    van Rensburg SJ; Peeters AV; van Toorn R; Schoeman J; Moremi KE; van Heerden CJ; Kotze MJ
    Mol Genet Metab Rep; 2019 Jun; 19():100465. PubMed ID: 30963028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis-like diagnosis as a complication of previously treated malaria in an iron and vitamin D deficient Nigerian patient.
    van Rensburg SJ; van Toorn R; Moremi KE; Peeters AV; Oguniyi A; Kotze MJ
    Metab Brain Dis; 2016 Feb; 31(1):197-204. PubMed ID: 26746433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals.
    Hagemeier J; Ramanathan M; Schweser F; Dwyer MG; Lin F; Bergsland N; Weinstock-Guttman B; Zivadinov R
    Neuroimage Clin; 2018; 17():530-540. PubMed ID: 29201641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology-supported genetic testing presents opportunities for improved disability outcomes in multiple sclerosis.
    Johannes C; Moremi KE; Kemp MC; Whati L; Engel-Hills P; Kidd M; van Toorn R; Jaftha M; van Rensburg SJ; Kotze MJ
    Per Med; 2023 Mar; 20(2):107-130. PubMed ID: 37194915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and diagnostic features of patients with familial multiple sclerosis.
    Andrijauskis D; Balnyte R; Keturkaite I; Vaitkus A
    Med Hypotheses; 2019 Oct; 131():109310. PubMed ID: 31443766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI.
    Kitzler HH; Su J; Zeineh M; Harper-Little C; Leung A; Kremenchutzky M; Deoni SC; Rutt BK
    Neuroimage; 2012 Feb; 59(3):2670-7. PubMed ID: 21920444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla.
    Bagnato F; Hametner S; Yao B; van Gelderen P; Merkle H; Cantor FK; Lassmann H; Duyn JH
    Brain; 2011 Dec; 134(Pt 12):3602-15. PubMed ID: 22171355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The conundrum of iron in multiple sclerosis--time for an individualised approach.
    van Rensburg SJ; Kotze MJ; van Toorn R
    Metab Brain Dis; 2012 Sep; 27(3):239-53. PubMed ID: 22422107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exome Sequencing in a Family with Luminal-Type Breast Cancer Underpinned by Variation in the Methylation Pathway.
    van der Merwe N; Peeters AV; Pienaar FM; Bezuidenhout J; van Rensburg SJ; Kotze MJ
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.
    Rudick RA; Lee JC; Nakamura K; Fisher E
    J Neurol Sci; 2009 Jul; 282(1-2):106-11. PubMed ID: 19100997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison study of inhomogeneous magnetization transfer (ihMT) and magnetization transfer (MT) in multiple sclerosis based on whole brain acquisition at 3.0 T.
    Zhang L; Wen B; Chen T; Tian H; Xue H; Ren H; Li L; Fan Q; Ren Z
    Magn Reson Imaging; 2020 Jul; 70():43-49. PubMed ID: 32224092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.
    Gemmati D; Zeri G; Orioli E; De Gaetano FE; Salvi F; Bartolomei I; D'Alfonso S; Dall'osso C; Leone MA; Singh AV; Asselta R; Zamboni P
    BMC Med Genet; 2012 Aug; 13():70. PubMed ID: 22883388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary influence on central nervous system myelin production, injury, and regeneration.
    Langley MR; Triplet EM; Scarisbrick IA
    Biochim Biophys Acta Mol Basis Dis; 2020 Jul; 1866(7):165779. PubMed ID: 32224154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cuprizone Administration Alters the Iron Metabolism in the Mouse Model of Multiple Sclerosis.
    Varga E; Pandur E; Abrahám H; Horváth A; Ács P; Komoly S; Miseta A; Sipos K
    Cell Mol Neurobiol; 2018 Jul; 38(5):1081-1097. PubMed ID: 29464444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic medicine and risk prediction across the disease spectrum.
    Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
    Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.